amiodarone has been researched along with Abnormality, Heart in 36 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) is a recognized complication of amiodarone treatment with limited management options." | 9.17 | Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study. ( Ammash, NM; Bahn, RS; Brennan, MD; Nannenga, MR; Stan, MN; Thapa, P; Warnes, CA, 2013) |
| "BACKGROUND Amiodarone-induced thyrotoxicosis can be refractory to medical treatment seldom requiring surgical intervention." | 7.96 | Surgical Treatment of Amiodarone-Induced Thyrotoxicosis in an Adult with Congenital Heart Disease: An Anesthetists Perspective. ( Al-Halabi, E; El-Asmar, JM; Naja, AS, 2020) |
| "Amiodarone (AMD) is a class III anti-arrhythmic drug that is highly effective for tachyarrhythmia treatment." | 7.88 | Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease. ( Hamamichi, Y; Inage, A; Ishii, T; Iwasawa, S; Saito, M; Uyeda, T; Yazaki, S; Yoshikawa, T, 2018) |
| "The development of amiodarone-induced thyrotoxicosis (AIT) can threaten the hemodynamic stability of adult patients with congenital heart disease (CHD)." | 7.80 | Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy. ( Bahn, RS; Brennan, MD; Sathananthan, M; Stan, MN; Thapa, P; Warnes, CA, 2014) |
| "To report a case of postnatal, postoperative amiodarone-induced hypothyroidism in an infant with a congenital heart defect." | 7.77 | Severe amiodarone-induced hypothyroidism in an infant. ( Panagiotopoulos, C; Sanatani, S; Trudel, K, 2011) |
| "Early treatment of postoperative tachyarrhythmia with amiodarone according to a standardized treatment protocol is safe and has beneficial effects on arrhythmia control and pediatric cardiac intensive care unit stay." | 7.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a recognized complication of amiodarone treatment with limited management options." | 5.17 | Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study. ( Ammash, NM; Bahn, RS; Brennan, MD; Nannenga, MR; Stan, MN; Thapa, P; Warnes, CA, 2013) |
| " In particular, we reviewed the effects of cyanosis, coarctation of the aorta, endocarditis, and the side effects of Sildenafil and Amiodarone." | 4.98 | The eye in CHD. ( Celermajer, D; Cordina, R; Liew, G; McCluskey, P; Nasir-Ahmad, S, 2018) |
| "BACKGROUND Amiodarone-induced thyrotoxicosis can be refractory to medical treatment seldom requiring surgical intervention." | 3.96 | Surgical Treatment of Amiodarone-Induced Thyrotoxicosis in an Adult with Congenital Heart Disease: An Anesthetists Perspective. ( Al-Halabi, E; El-Asmar, JM; Naja, AS, 2020) |
| "Amiodarone (AMD) is a class III anti-arrhythmic drug that is highly effective for tachyarrhythmia treatment." | 3.88 | Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease. ( Hamamichi, Y; Inage, A; Ishii, T; Iwasawa, S; Saito, M; Uyeda, T; Yazaki, S; Yoshikawa, T, 2018) |
| "The development of amiodarone-induced thyrotoxicosis (AIT) can threaten the hemodynamic stability of adult patients with congenital heart disease (CHD)." | 3.80 | Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy. ( Bahn, RS; Brennan, MD; Sathananthan, M; Stan, MN; Thapa, P; Warnes, CA, 2014) |
| "To report a case of postnatal, postoperative amiodarone-induced hypothyroidism in an infant with a congenital heart defect." | 3.77 | Severe amiodarone-induced hypothyroidism in an infant. ( Panagiotopoulos, C; Sanatani, S; Trudel, K, 2011) |
| "Early treatment of postoperative tachyarrhythmia with amiodarone according to a standardized treatment protocol is safe and has beneficial effects on arrhythmia control and pediatric cardiac intensive care unit stay." | 3.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "A 33-year-old woman with congenital heart disease and atrial and ventricular arrhythmias, managed over the long term with an implantable cardioverter defibrillator, epicardial pacing system, and amiodarone, experienced an increase in palpitations and a shock from her defibrillator." | 3.70 | Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease. ( Costanzo, MR; Fischer, SA; Porter, MT; Santucci, PA; Trohman, RG; Zarembski, DG, 1999) |
| "Our use of amiodarone in 200 patients during an 8-year period confirms our previous experience which indicated that the drug was close to being the ideal antiarrhythmic agent in children's arrhythmias." | 3.66 | The use of amiodarone in children. ( Coumel, P; Do Ngoc, D; Lucet, V, 1983) |
| " Prophylactic amiodarone is safe and effective in preventing early JET in children after open heart surgery." | 2.82 | Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor. ( Amrousy, DE; Elshehaby, W; Elshmaa, NS; Feky, WE, 2016) |
| "Atrial flutter was present in 16 patients, ventricular tachycardia in 14 patients and supraventricular tachycardia in 9 patients." | 2.65 | Amiodarone treatment of critical arrhythmias in children and young adults. ( Angell, LK; Garson, A; Gillette, PC; Hesslein, PS; Hittner, HM; Kaldis, LC; McVey, P; Porter, CJ, 1984) |
| "Patients with congenital heart disease have higher prevalence of thyroid dysfunction due to embryonic and genetic coexistence." | 2.61 | Congenital Heart Disease and Thyroid Dysfunction: Combination, Association, and Implication. ( Gruber, N; Lerner, RK; Pollak, U, 2019) |
| "The diagnosis of Junctional Ectopic Tachycardia can be made on a 12-lead ECG, demonstrating a narrow-complex tachycardia with inverted P-waves and VA dissociation." | 2.50 | Junctional ectopic tachycardia after congenital heart surgery. ( Cools, E; Missant, C, 2014) |
| "Postoperative junctional ectopic tachycardia (JET) is a potential life-threatening tachycardia that mainly occurs after surgical correction of congenital heart defects." | 2.42 | Postoperative junctional ectopic tachycardia (JET). ( Haas, NA; Jalali, H; Justo, R; Plumpton, K; Pohlner, P, 2004) |
| "Amiodarone was successful in treating JET in 75% of cases; sotalol was successful in 83%." | 1.72 | Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgery. ( Asadourian, V; Howard, TS; Kim, JJ; Lemming, K; Miyake, CY; Patel, R; Pham, TDN; Rochelson, E; Valdés, SO, 2022) |
| " We sought to determine incidence and predictors of adverse effects caused by amiodarone in adult CHD (ACHD)." | 1.48 | Adverse effects of amiodarone therapy in adults with congenital heart disease. ( Celermajer, DS; Cordina, RL; McGuire, MA; Moore, BM, 2018) |
| "Intravenous amiodarone alone or in combination with digoxin was found to be safe and effective in controlling refractory and life-threatening SVT in neonates and small infants." | 1.36 | Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. ( Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M, 2010) |
| "Amiodarone was the initial therapy in 26 cases and procainamide in 14 cases." | 1.36 | Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. ( Bar-Cohen, Y; Chang, PM; Moromisato, DY; Silka, MJ, 2010) |
| "Amiodarone was suggested to be an adequate treatment; however, data regarding its efficacy and safety are limited." | 1.35 | Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. ( Dobos, D; Hakacova, N; Kovacikova, L; Skrak, P; Zahorec, M, 2009) |
| "Post-operative junctional ectopic tachycardia is a transient, but potentially life threatening, rapid automatic tachyarrhythmia that requires urgent and adequate treatment." | 1.33 | Amiodarone for post-operative junctional ectopic tachycardia. ( Haas, N; Justo, R; Plumpton, K, 2005) |
| "Flutter-like arrhythmias occur mainly after atrial surgery (closure of atrial septal defects, Mustard, Senning or Fontan procedures)." | 1.31 | [Arrhythmias after surgery for congenital heart disease]. ( Lucet, V, 2002) |
| "Prevention of recurrence with oral amiodarone was effective in all cases but was responsible for secondary effects in 4 cases." | 1.29 | [Late supraventricular arrhythmia complicating Fontan or cavopulmonary type procedures. Apropos of 7 cases]. ( David, N; Foucault, JP; Iselin, M; Maragnès, P; Villain, E, 1996) |
| " The mean maintenance dosage was 7." | 1.28 | Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. ( Garson, A; Guccione, P; Paul, T, 1990) |
| "Supraventricular tachycardia is one of the most frequent arrhythmias in childhood." | 1.27 | [Supraventricular tachycardia in children]. ( Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F, 1983) |
| "Digoxin half-life was prolonged." | 1.27 | Digoxin toxicity associated with amiodarone therapy in children. ( Hesslein, PS; Koren, G; MacLeod, SM, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 13 (36.11) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rochelson, E | 1 |
| Valdés, SO | 1 |
| Asadourian, V | 1 |
| Patel, R | 1 |
| Lemming, K | 1 |
| Howard, TS | 1 |
| Pham, TDN | 1 |
| Miyake, CY | 1 |
| Kim, JJ | 1 |
| Kikano, S | 1 |
| Kannankeril, PJ | 1 |
| Lerner, RK | 1 |
| Gruber, N | 1 |
| Pollak, U | 1 |
| El-Asmar, JM | 1 |
| Naja, AS | 1 |
| Al-Halabi, E | 1 |
| Webster, G | 1 |
| Iwasawa, S | 1 |
| Uyeda, T | 1 |
| Saito, M | 1 |
| Ishii, T | 1 |
| Inage, A | 1 |
| Hamamichi, Y | 1 |
| Yazaki, S | 1 |
| Yoshikawa, T | 1 |
| Nasir-Ahmad, S | 1 |
| Cordina, R | 1 |
| Liew, G | 1 |
| McCluskey, P | 1 |
| Celermajer, D | 1 |
| Moore, BM | 1 |
| Cordina, RL | 1 |
| McGuire, MA | 1 |
| Celermajer, DS | 1 |
| Stan, MN | 2 |
| Sathananthan, M | 1 |
| Warnes, CA | 2 |
| Brennan, MD | 2 |
| Thapa, P | 2 |
| Bahn, RS | 2 |
| Cools, E | 1 |
| Missant, C | 1 |
| Takeuchi, D | 1 |
| Honda, K | 1 |
| Shinohara, T | 1 |
| Inai, K | 1 |
| Toyohara, K | 1 |
| Nakanishi, T | 1 |
| Amrousy, DE | 1 |
| Elshehaby, W | 1 |
| Feky, WE | 1 |
| Elshmaa, NS | 1 |
| Haas, NA | 3 |
| Camphausen, CK | 2 |
| Kovacikova, L | 1 |
| Hakacova, N | 1 |
| Dobos, D | 1 |
| Skrak, P | 1 |
| Zahorec, M | 1 |
| Dilber, E | 1 |
| Mutlu, M | 1 |
| Dilber, B | 1 |
| Aslan, Y | 1 |
| Gedik, Y | 1 |
| Celiker, A | 1 |
| Chang, PM | 1 |
| Silka, MJ | 1 |
| Moromisato, DY | 1 |
| Bar-Cohen, Y | 1 |
| Trudel, K | 1 |
| Sanatani, S | 1 |
| Panagiotopoulos, C | 1 |
| Ammash, NM | 1 |
| Nannenga, MR | 1 |
| Hoffman, TM | 1 |
| Bush, DM | 1 |
| Wernovsky, G | 1 |
| Cohen, MI | 1 |
| Wieand, TS | 1 |
| Gaynor, JW | 1 |
| Spray, TL | 1 |
| Rhodes, LA | 1 |
| Lucet, V | 2 |
| Plumpton, K | 2 |
| Justo, R | 2 |
| Jalali, H | 1 |
| Pohlner, P | 1 |
| Haas, N | 1 |
| Coumel, P | 1 |
| Do Ngoc, D | 1 |
| Garson, A | 2 |
| Gillette, PC | 1 |
| McVey, P | 1 |
| Hesslein, PS | 2 |
| Porter, CJ | 1 |
| Angell, LK | 1 |
| Kaldis, LC | 1 |
| Hittner, HM | 1 |
| Battaglia, T | 1 |
| Paparo, F | 1 |
| Fumarulo, A | 1 |
| Attanà, A | 1 |
| Ciconte, V | 1 |
| Caristo, S | 1 |
| Martini, B | 1 |
| Koren, G | 1 |
| MacLeod, SM | 1 |
| Foster, CJ | 1 |
| Maragnès, P | 1 |
| Villain, E | 2 |
| Iselin, M | 1 |
| David, N | 1 |
| Foucault, JP | 1 |
| Zarembski, DG | 1 |
| Fischer, SA | 1 |
| Santucci, PA | 1 |
| Porter, MT | 1 |
| Costanzo, MR | 1 |
| Trohman, RG | 1 |
| Thorne, SA | 1 |
| Barnes, I | 1 |
| Cullinan, P | 1 |
| Somerville, J | 1 |
| Dodge-Khatami, A | 1 |
| Miller, OI | 1 |
| Anderson, RH | 1 |
| Gil-Jaurena, JM | 1 |
| Goldman, AP | 1 |
| de Leval, MR | 1 |
| Guccione, P | 1 |
| Paul, T | 1 |
| Zeevi, B | 1 |
| Berant, M | 1 |
| Sclarovsky, S | 1 |
| Blieden, LC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Study for the Prevention of Post-Operative Cardiac Arrhythmias[NCT04234906] | Phase 4 | 870 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | ||
| "Population Pharmacokinetics and Pharmacodynamics of Amiodarone in Children: PK-AMIO"[NCT03842020] | 57 participants (Actual) | Interventional | 2019-02-13 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for amiodarone and Abnormality, Heart
| Article | Year |
|---|---|
Congenital Heart Disease and Thyroid Dysfunction: Combination, Association, and Implication.
Topics: Adolescent; Amiodarone; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child, Preschool | 2019 |
The eye in CHD.
Topics: Adult; Amiodarone; Aortic Coarctation; Cyanosis; Endocarditis; Eye Diseases; Heart Defects, Congenit | 2018 |
Junctional ectopic tachycardia after congenital heart surgery.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Proced | 2014 |
Postoperative junctional ectopic tachycardia (JET).
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiovascular Surgical Procedures; | 2004 |
3 trials available for amiodarone and Abnormality, Heart
| Article | Year |
|---|---|
Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Child; Egypt; Female; Heart | 2016 |
Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Body Mass Index; Cohort Studies; Databases, Factual; Fema | 2013 |
Amiodarone treatment of critical arrhythmias in children and young adults.
Topics: Adolescent; Adult; Amiodarone; Atrial Flutter; Benzofurans; Child; Child, Preschool; Clinical Trials | 1984 |
29 other studies available for amiodarone and Abnormality, Heart
| Article | Year |
|---|---|
Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Heart Defects, Congenital; Humans; Retrospective St | 2022 |
Sotalol vs amiodarone for postoperative junctional ectopic tachycardia: Citius, Altius, Fortius?
Topics: Amiodarone; Heart Defects, Congenital; Humans; Sotalol; Tachycardia, Ectopic Junctional | 2022 |
Surgical Treatment of Amiodarone-Induced Thyrotoxicosis in an Adult with Congenital Heart Disease: An Anesthetists Perspective.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Heart Defects, Congenital; Humans; Male; Thyroidectomy; T | 2020 |
Aiming at a Blurry Target: Optimal Therapy for Postoperative JET.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Defects, Congenital; Humans; Infant; Postoperative Complic | 2017 |
Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart De | 2018 |
Adverse effects of amiodarone therapy in adults with congenital heart disease.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Drug | 2018 |
Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy.
Topics: Adult; Amiodarone; Female; Heart Defects, Congenital; Humans; Male; Retrospective Studies; Thyrotoxi | 2014 |
Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease.
Topics: Adolescent; Adult; Amiodarone; Asian People; Female; Follow-Up Studies; Heart Defects, Congenital; H | 2015 |
Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.
Topics: Adolescent; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Catecholami | 2008 |
Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Central Venous Pressure; Critical Care; Heart De | 2008 |
Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Surgical Procedures; Child; Child, Presc | 2009 |
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therap | 2010 |
Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Hear | 2010 |
Severe amiodarone-induced hypothyroidism in an infant.
Topics: Amiodarone; Female; Heart Defects, Congenital; Humans; Hypothyroidism; Infant; Thyroid Function Test | 2011 |
Index of suspicion.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cranial Nerve Neoplasms; Digoxin; Down Syndrome; D | 2002 |
Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment.
Topics: Amiodarone; Cardiac Pacing, Artificial; Child; Child, Preschool; Dopamine; Female; Heart Defects, Co | 2002 |
[Arrhythmias after surgery for congenital heart disease].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroencephalography; Exercise Test; Hea | 2002 |
Amiodarone for post-operative junctional ectopic tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Heart Defects, Congenital; Heart Se | 2005 |
The use of amiodarone in children.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Bundle-Branch Bl | 1983 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart D | 1983 |
Digoxin toxicity associated with amiodarone therapy in children.
Topics: Adolescent; Amiodarone; Benzofurans; Cardiomyopathy, Dilated; Child; Child, Preschool; Creatinine; D | 1984 |
Amiodarone in pregnancy.
Topics: Abnormalities, Drug-Induced; Amiodarone; Female; Heart Defects, Congenital; Humans; Infant, Newborn; | 1994 |
[Late supraventricular arrhythmia complicating Fontan or cavopulmonary type procedures. Apropos of 7 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Premature Complexes; Cardiac Pacing, Arti | 1996 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease.
Topics: Adult; Amiodarone; Antibiotics, Antitubercular; Arrhythmias, Cardiac; Defibrillators, Implantable; F | 1999 |
Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Female; Heart Defects, | 1999 |
Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects.
Topics: Amiodarone; Analysis of Variance; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Child; Ch | 2002 |
Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Child; | 1990 |
Treatment of multifocal atrial tachycardia with amiodarone in a child with congenital heart disease.
Topics: Amiodarone; Benzofurans; Child, Preschool; Electrocardiography; Heart Defects, Congenital; Heart Fai | 1986 |